InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: None

Sunday, 05/22/2016 12:13:32 PM

Sunday, May 22, 2016 12:13:32 PM

Post# of 232092
Lets not forget ASM selected CYDY for an ASM press release-
“We are honored that not only ASM Microbe Conference has accepted our abstract and granted us an oral presentation spot, but has also selected our abstract for an ASM-sponsored press release to highlight our research to the journalists covering this Conference,” said Nader Pourhassan, PhD, the president and CEO of CytoDyn. “We believe that PRO 140 has great potential as an alternative or addition to current standard of care and is currently conducting two phase 3 trials for both of these populations.”
Chump
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News